Viral Vector Gene Delivery Market

Table of Content

1. Introduction

• Report scope
• Inclusion, Exclusion criteria and Assumptions

2. Executive Summary

3. Multi-scenario Market Forecast to 2027

• Global Market Analysis

• Regional Market Analysis

  • North America (The USA, Canada)

  • Europe (Germany, France, Spain, Italy) and UK

  • Asia (Japan, South Korea)

  • BRIC (Brazil, Russia, India, China)

4. Market size by Drug Class

• Revenue Forecast by Molecular Target Class

5. Market Dynamics

• Regulatory Landscape

• Key Marketed Products

• Overview

• Catalyst

6. Pipeline Landscape Assessment

• Overview

• Pipeline Development Landscape

• Attribute Analysis

• Pipeline Valuation Analysis (Late-Stage Products)

7. Clinical Trials Analytics

• Clinical Trial Failure Rates

• Clinical Trial Duration

• Clinical Trial Size

8. Value Chain

• Supply Chain Analysis

• COVID-19 Impact Analysis

• Burning Issues

9. R&D Strategies

• Overview

• R&D strategies from business perspective

• Label Expansions into Other Line of Therapy

10. Company Analysis and Positioning

• Competitive Assessment

• Company information (Funding/investment analysis)

  • Key & Established players

  • Upcoming/Start-ups

  • Marketed and Pipeline Portfolio Analysis

11. Strategic Consolidations

• Licensing Deals

• Co-development Deals

12. Key Opportunities

• Unmet Needs

• Opportunity Assessment

13. About us

• Research Methodology

• Bibliography